Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,345 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Quality indicators in the intensity modulated/image-guided radiotherapy era.
Gabriele P, Maggio A, Garibaldi E, Bracco C, Delmastro E, Gabriele D, Rosi A, Munoz F, Di Muzio N, Corvò R, Stasi M. Gabriele P, et al. Among authors: munoz f. Crit Rev Oncol Hematol. 2016 Dec;108:52-61. doi: 10.1016/j.critrevonc.2016.10.013. Epub 2016 Nov 2. Crit Rev Oncol Hematol. 2016. PMID: 27931840 Review.
Predictors for rectal and intestinal acute toxicities during prostate cancer high-dose 3D-CRT: results of a prospective multicenter study.
Vavassori V, Fiorino C, Rancati T, Magli A, Fellin G, Baccolini M, Bianchi C, Cagna E, Mauro FA, Monti AF, Munoz F, Stasi M, Franzone P, Valdagni R. Vavassori V, et al. Among authors: munoz f. Int J Radiat Oncol Biol Phys. 2007 Apr 1;67(5):1401-10. doi: 10.1016/j.ijrobp.2006.10.040. Epub 2007 Jan 22. Int J Radiat Oncol Biol Phys. 2007. PMID: 17241754
Prospective phase II trial of neoadjuvant chemo-radiotherapy with Oxaliplatin and Capecitabine in locally advanced rectal cancer (XELOXART).
Ricardi U, Racca P, Franco P, Munoz F, Fanchini L, Rondi N, Dongiovanni V, Gabriele P, Cassoni P, Ciuffreda L, Morino M, Filippi AR, Aglietta M, Bertetto O. Ricardi U, et al. Among authors: munoz f. Med Oncol. 2013;30(2):581. doi: 10.1007/s12032-013-0581-0. Epub 2013 Apr 19. Med Oncol. 2013. PMID: 23606239 Clinical Trial.
Daily sodium butyrate enema for the prevention of radiation proctitis in prostate cancer patients undergoing radical radiation therapy: results of a multicenter randomized placebo-controlled dose-finding phase 2 study.
Maggio A, Magli A, Rancati T, Fiorino C, Valvo F, Fellin G, Ricardi U, Munoz F, Cosentino D, Cazzaniga LF, Valdagni R, Vavassori V. Maggio A, et al. Among authors: munoz f. Int J Radiat Oncol Biol Phys. 2014 Jul 1;89(3):518-24. doi: 10.1016/j.ijrobp.2014.03.018. Epub 2014 May 3. Int J Radiat Oncol Biol Phys. 2014. PMID: 24803033 Clinical Trial.
Three-dimensional ultrasound-based image-guided hypofractionated radiotherapy for intermediate-risk prostate cancer: results of a consecutive case series.
Ricardi U, Franco P, Munoz F, Levis M, Fiandra C, Guarneri A, Moretto F, Bartoncini S, Arcadipane F, Badellino S, Piva C, Trino E, Ruggieri A, Filippi AR, Ragona R. Ricardi U, et al. Among authors: munoz f. Cancer Invest. 2015 Mar;33(2):23-8. doi: 10.3109/07357907.2014.988343. Epub 2014 Dec 19. Cancer Invest. 2015. PMID: 25526035
Intensity-modulated radiation therapy with simultaneous integrated boost combined with concurrent chemotherapy for the treatment of anal cancer patients: 4-year results of a consecutive case series.
Franco P, Mistrangelo M, Arcadipane F, Munoz F, Sciacero P, Spadi R, Migliaccio F, Angelini V, Bombaci S, Rondi N, Numico G, Ragona R, Cassoni P, Morino M, Racca P, Ricardi U. Franco P, et al. Among authors: munoz f. Cancer Invest. 2015 Jul;33(6):259-66. doi: 10.3109/07357907.2015.1028586. Epub 2015 May 7. Cancer Invest. 2015. PMID: 25950188 Clinical Trial.
1,345 results